248 related articles for article (PubMed ID: 28285560)
1. Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation.
Doh EJ; Ohn J; Kim MJ; Kim YG; Cho S
J Dermatolog Treat; 2017 Nov; 28(7):672-677. PubMed ID: 28285560
[TBL] [Abstract][Full Text] [Related]
2. Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment.
Griffin TD; Foshee JP; Finney R; Saedi N
Lasers Surg Med; 2016 Feb; 48(2):193-6. PubMed ID: 26503090
[TBL] [Abstract][Full Text] [Related]
3. Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial.
Greveling K; Prens EP; van Doorn MB
Lasers Surg Med; 2017 Jan; 49(1):104-109. PubMed ID: 27320685
[TBL] [Abstract][Full Text] [Related]
4. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks.
Chang CJ; Hsiao YC; Mihm MC; Nelson JS
Lasers Surg Med; 2008 Nov; 40(9):605-10. PubMed ID: 18951427
[TBL] [Abstract][Full Text] [Related]
5. Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application.
Artzi O; Mehrabi JN; Heyman L; Friedman O; Mashiah J
Dermatol Ther; 2020 Jan; 33(1):e13172. PubMed ID: 31747115
[TBL] [Abstract][Full Text] [Related]
6. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial.
Marqués L; Núñez-Córdoba JM; Aguado L; Pretel M; Boixeda P; Nagore E; Baselga E; Redondo P
J Am Acad Dermatol; 2015 Jan; 72(1):151-8.e1. PubMed ID: 25455610
[TBL] [Abstract][Full Text] [Related]
7. Topical Adjuncts to Pulsed Dye Laser for Treatment of Port Wine Stains: Review of the Literature.
Lipner SR
Dermatol Surg; 2018 Jun; 44(6):796-802. PubMed ID: 29799824
[TBL] [Abstract][Full Text] [Related]
8. Pulsed dye laser and adjuvant topical therapies for the treatment of port-wine stains: A systematic review.
Chou M; Karim M; Josephs J; Itzkowitz T; Dreker MR; Labadie JG
Lasers Surg Med; 2024 Jan; 56(1):39-44. PubMed ID: 37431532
[TBL] [Abstract][Full Text] [Related]
9. Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks.
Loewe R; Oble DA; Valero T; Zukerberg L; Mihm MC; Nelson JS
J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):76-82. PubMed ID: 20482679
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Investigation of the Safety and Efficacy of Pulsed Dye Laser with Two Spot Sizes in Port-Wine Stain Treatment: A Prospective Side-by-Side Comparison.
Yu W; Ying H; Chen Y; Qiu Y; Chen H; Jin Y; Yang X; Wang T; Ma G; Lin X
Photomed Laser Surg; 2017 Sep; 35(9):465-471. PubMed ID: 28650740
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double-blind, placebo-controlled trial.
Fallahi M; Hallaji Z; Tavakolpour S; Niknam S; Salehi Farid A; Nili A; Teimourpour A; Daneshpazhooh M; Rahmati J; Haddady Abianeh S; Mahmoudi H
J Cosmet Dermatol; 2021 Aug; 20(8):2498-2506. PubMed ID: 33251650
[TBL] [Abstract][Full Text] [Related]
12. Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone.
Musalem HM; Alshaikh AA; Tuleimat LM; Alajlan S
Ann Saudi Med; 2018; 38(5):376-380. PubMed ID: 30284993
[TBL] [Abstract][Full Text] [Related]
13. Delayed ulceration following combination pulse dye laser and topical sirolimus treatment for port wine birthmarks: A case series.
Hobayan CGP; Nourse EJ; Paradiso MM; Fernandez Faith E
Pediatr Dermatol; 2024; 41(1):108-111. PubMed ID: 37571864
[TBL] [Abstract][Full Text] [Related]
14. Topical application of 5-aminolevulinic acid followed by 595-nm pulsed dye laser irradiation for the treatment of recalcitrant port-wine stains: a primary study.
Liu S; Yang C; Yang S; Wang Z; Luo D; Zhang X
J Cosmet Laser Ther; 2012 Aug; 14(4):189-92. PubMed ID: 22658236
[TBL] [Abstract][Full Text] [Related]
15. Pulsed dye laser treatment of capillary malformations in infants at 2-weekly versus 3-monthly intervals, reducing the need for general anaesthesia.
Swan BC; Robertson SJ; Tuxen A; Ma E; Yip L; Ly L; Bingham L; Davidson A; Bekhor P
Australas J Dermatol; 2017 Aug; 58(3):214-218. PubMed ID: 26914597
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recalcitrant port-wine stains (PWS) using a combined pulsed dye laser (PDL) and radiofrequency (RF) energy device.
Bae YC; Alabdulrazzaq H; Brauer JA; Geronemus RG
J Am Acad Dermatol; 2017 Feb; 76(2):321-326. PubMed ID: 28088993
[TBL] [Abstract][Full Text] [Related]
17. Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels.
Tan W; Jia W; Sun V; Mihm MC; Nelson JS
Lasers Surg Med; 2012 Dec; 44(10):796-804. PubMed ID: 23213008
[TBL] [Abstract][Full Text] [Related]
18. Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial.
Passeron T; Maza A; Fontas E; Toubel G; Vabres P; Livideanu C; Mazer JM; Rossi B; Boukari F; Harmelin Y; Dreyfus I; Mazereeuw-Hautier J; Lacour JP
Br J Dermatol; 2014 Jun; 170(6):1350-3. PubMed ID: 24641096
[TBL] [Abstract][Full Text] [Related]
19. Side-by-side comparison of photodynamic therapy and pulsed-dye laser treatment of port-wine stain birthmarks.
Gao K; Huang Z; Yuan KH; Zhang B; Hu ZQ
Br J Dermatol; 2013 May; 168(5):1040-6. PubMed ID: 23137063
[TBL] [Abstract][Full Text] [Related]
20. Topical metformin suppresses angiogenesis pathways induced by pulsed dye laser irradiation in animal models.
Wang M; Lin Y; Shi W; Chen X; Mi Z; Jia Z; Pan Q; Wang Z; Han J; Liu H
Exp Dermatol; 2022 Mar; 31(3):393-397. PubMed ID: 34564891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
